Literature DB >> 8931570

Pathology of acute and chronic ischaemic neuropathy in atherosclerotic peripheral vascular disease.

H Nukada1, A M van Rij, S G Packer, P D McMorran.   

Abstract

The peripheral nerve pathology in ischaemic limbs with atherosclerotic peripheral vascular diseases (PVD) is difficult to ascertain because of the limited number of reports. In addition, it has been debated whether chronic ischaemia per se could cause morphological abnormalities in peripheral nerves. In this prospective study, we examined pathological findings in the sural, saphenous, deep peroneal, superficial peroneal and tibial nerves, taken from seven acutely and nine chronically ischaemic amputated legs in which ischaemia was due to non-diabetic severe PVD. For morphological comparison, nerves were also taken from amputated legs without ischaemic disease and those in which PVD was associated with diabetes. In acutely ischaemic nerves, pathological changes were dependent upon the duration of ischaemia. Axonal degeneration of both myelinated and unmyelinated nerve fibres (MFs and UMFs) with occluded vessels was prominent, if acute ischaemia was present for > 24 h. Focal lesions, a hallmark of acute ischaemic neuropathy, were seen in both acute and chronic PVD nerves. Chronic PVD nerves also revealed considerable variations in the density of MFs between the fascicles of individual nerves and between the nerves of individual subjects: demyelination and remyelination, endoneurial oedema particularly at the subperineurial region, swollen endothelial cells, various but infrequent axonal changes, and relative preservation of UMFs were also seen. All pathological changes found in acute and chronic PVD nerves, except for a high rate demyelinated and remyelinated nerve fibres, have been described in experimental models of acute ischaemic/reperfusion injury. Demyelination could be induced by chronic ischaemia. Thus, pathological alterations in chronic ischaemic neuropathy may be due to the combined effects of acute ischaemia/reperfusion and chronic hypoxia.

Entities:  

Mesh:

Year:  1996        PMID: 8931570     DOI: 10.1093/brain/119.5.1449

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  11 in total

1.  4-Phenylbutyric acid protects against vasculitic peripheral neuropathy induced by ischaemia-reperfusion through attenuating endoplasmic reticulum stress.

Authors:  Cay-Huyen Chen; Ping-Chen Shih; Han-Yu Lin; Po-Kai Wang; Po-Ting Pan; Ching-Wei Chuang; Ming-Chang Kao
Journal:  Inflammopharmacology       Date:  2019-05-22       Impact factor: 4.473

2.  Vascular factors predict polyneuropathy in a non-diabetic elderly population.

Authors:  Marzia Baldereschi; Marco Inzitari; Antonio Di Carlo; Francesca Bovis; Stefania Maggi; Antonio Capurso; Vincenzo Solfrizzi; Francesco Panza; Emanuele Scafato; Domenico Inzitari
Journal:  Neurol Sci       Date:  2012-08-15       Impact factor: 3.307

3.  The Effect of Lutein on Ischemia-reperfusion-induced Vasculitic Neuropathic Pain and Neuropathy in Rats.

Authors:  Sahin Yuceli; Gulce Naz Yazici; Renad Mammadov; Halis Suleyman; Selcuk Ozdogan
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

4.  Is cardiovascular disease a risk factor in the development of axonal polyneuropathy?

Authors:  L L Teunissen; H Franssen; J H J Wokke; Y van der Graaf; W H J P Linssen; J D Banga; D M Laman; N C Notermans
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

5.  [Correlation between quantitative sensory testing and questionnaires on neuropathic pain for chronic ischemic pain in peripheral arterial disease].

Authors:  P M Lang; L J Rüger; T Abahji; U Hoffmann; A Crispin; D Irnich
Journal:  Schmerz       Date:  2009-06       Impact factor: 1.107

6.  Right calf claudication revealing leriche syndrome presenting as right sciatic neuropathy.

Authors:  Do Hyun Yoon; Hyungpil Cho; Seung Jun Seol; Taikon Kim
Journal:  Ann Rehabil Med       Date:  2014-02-25

7.  Morphometric analysis of connective tissue sheaths of sural nerve in diabetic and nondiabetic patients.

Authors:  Braca Kundalić; Slađana Ugrenović; Ivan Jovanović; Natalija Stefanović; Vladimir Petrović; Jasen Kundalić; Vesna Stojanović; Vladimir Živković; Vladimir Antić
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

8.  CD40-mediated HIF-1α expression underlying microangiopathy in diabetic nerve pathology.

Authors:  Hung-Wei Kan; Jung-Hsien Hsieh; Hsiung-Fei Chien; Yea-Huey Lin; Ti-Yen Yeh; Chi-Chao Chao; Sung-Tsang Hsieh
Journal:  Dis Model Mech       Date:  2018-04-26       Impact factor: 5.758

9.  The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET.

Authors:  K Kahnert; M Föhrenbach; T Lucke; P Alter; F T Trudzinski; R Bals; J I Lutter; H Timmermann; S Söhler; S Förderreuther; D Nowak; H Watz; B Waschki; J Behr; T Welte; C F Vogelmeier; R A Jörres
Journal:  Respir Res       Date:  2020-01-20

Review 10.  ANCA-Associated Vasculitic Neuropathies: A Review.

Authors:  Haruki Koike; Ryoji Nishi; Ken Ohyama; Saori Morozumi; Yuichi Kawagashira; Soma Furukawa; Naohiro Mouri; Yuki Fukami; Masahiro Iijima; Gen Sobue; Masahisa Katsuno
Journal:  Neurol Ther       Date:  2022-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.